The changing face of methicillin-resistant Staphylococcus aureus infections

Alistair T Leanord and John Coia
Med J Aust 2017; 207 (9): . || doi: 10.5694/mja17.00641
Published online: 6 November 2017

Further success in controlling MRSA will require adapting our tactics to its shifting epidemiology

There is an ongoing global endeavour to reduce the incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections in health care settings. The major specific focus has been reducing MRSA transmission in hospitals, applying a combination of admission screening, isolation, and decolonisation, an approach allied to standard infection control precautions.1 In several countries this has significantly reduced the rate of serious MRSA infections, defined as the proportion of S. aureus bacteraemias that are methicillin-resistant; the United Kingdom, for example, has experienced an almost 90% reduction in MRSA bacteraemias over ten years.2 Similarly large reductions in MRSA rates have been reported in Australia.3,4

  • Alistair T Leanord1
  • John Coia2

  • 1 NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom
  • 2 Scottish Microbiology Reference Laboratories, Glasgow, Scotland, United Kingdom

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.